cCMV
For newborns less than 21 days old with possible cCMV or maternal CMV exposure, early screening by Labcorp using DiaSorin Molecular's FDA-cleared Simplexa Congenital CMV Direct PCR urine and saliva test can help you start treatment earlier to reduce or prevent long-term complications.